Citations
Showing 10 of 108081 citations.
Dose-dense (DD) AC followed by paclitaxel is associated with moderate, frequent anemia compared to sequential (S) and/or less DD Treatment: Update by CALGB on Breast Cancer Intergroup Trial C9741 with ECOG, SWOG, & NCCTG
Citron, M., Berry, D. A., Cirrincione, C., Livingston, R. B., Gradishar, WJ, Pérez, E., Muss, Hyman B. , Winer, EP, Hudis, C., Norton, Larry
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 620-620
Chemotherapy error: Analysis of an error reporting database, recent case reports, error reduction methods, current reporting systems
Harris, Thomas J., Northfelt, Donald W.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6091-6091
Activity of oral irinotecan (IRI) in metastatic breast cancer (MBC) patients after prior anthracycline, taxane and capecitabine: Phase 2 study results
Vukelja, S., O’Shaughnessy, J., Blum, JL, Yardley, DA , Mainwaring, Paul N. , Senecal, Frank M., Benner, Rebecca, Denis, L., Pérez, E., Vukelja, Svetislava J., Campos-Gómez, Saúl , Vahdat, Linda T.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 562-562
Interim cardiac safety analysis of NCCTG N9831 Intergroup adjuvant trastuzumab trial
Perez, Edith A. , Davidson, Nancy E. , Martino, Silvana, Dakhil, Shaker R. , Rodeheffer, R.J., Jaffe, Allan S. , Suman, Vera J. , Kaufman, Peter A. , Ingle, James N. , Gersh, Bernard J. , Hillman, David W. , Jaffe, Allan S.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 556-556
E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer
Goldstein, Lori J. , O’Neill, Anne, Sparano, JA, Perez, EA, Shulman, L.P., Martino, Silvana, Davidson, N.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 512-512
Prognostic value of cell cycle regulators p27 and cyclin E: Tissue microarray analysis of 1753 women enrolled in SWOG breast cancer trial 9313
Porter, Peggy L. , Yeh, I‐Tien, Lin, M.‐G., Yuan, X., Shapiro, CL, Sledge, G. P., Livingston, R. B., Hayes, Daniel F. , Barlow, William E. , Ingle, James N.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 507-507
Prostate cancer: biopsy proven rare sites of metastases
Tan, Wei Phin , Wu, Kerui
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4794-4794
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia: A phase II study from the North Central Cancer Treatment Group
Jatoi, Aminah , Murphy, Brittany L. , Foster, Nathan R. , Nikcevich, Daniel A., Kugler, J. W., Fitch, Tom R., Luyun, Ronnie F., Alberts, Steven R.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4059-4059
A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99–04)
Okawara, Gordon, Winter, K., Donohue, J H, Pisters, Peter W. T., Crane, Christopher H. , Greskovich, J.F., Anné, P.R., Willet, Christopher G., Bradley, Jeffrey D. , Ajani, Jaffer A.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4019-4019
Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer
Harba, A., Peinert, Stefan, Grothe, Wilfried, Jordan, Karin , Kegel, Thomas, Mueller, Lutz Peter , Behrens, Robert J. , Grothey, Axel , Arnold, Dirk , Schmoll, Hans‐Joachim
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3719-3719